MARKET

HSCS

HSCS

HeartSciences Inc
NASDAQ
3.090
+0.115
+3.87%
Closed 16:00 12/31 EST
OPEN
3.010
PREV CLOSE
2.975
HIGH
3.129
LOW
2.950
VOLUME
37.04K
TURNOVER
--
52 WEEK HIGH
6.47
52 WEEK LOW
2.010
MARKET CAP
9.82M
P/E (TTM)
-0.4446
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HSCS last week (1222-1226)?
Weekly Report · 12/29/2025 09:08
Heart Test Laboratories: AI-Driven Cardiology Platform Nearing Regulatory Milestones Supports Upside and Buy Rating
TipRanks · 12/24/2025 12:05
HeartSciences Is Maintained at Buy by Ascendiant Capital
Dow Jones · 12/22/2025 10:48
HeartSciences Price Target Raised to $9.20/Share From $9.00 by Ascendiant Capital
Dow Jones · 12/22/2025 10:48
Ascendiant Capital Maintains Buy on HeartSciences, Raises Price Target to $9.2
Benzinga · 12/22/2025 10:38
Weekly Report: what happened at HSCS last week (1215-1219)?
Weekly Report · 12/22/2025 09:08
Analysts Are Bullish on These Healthcare Stocks: Radiopharm Theranostics Limited Sponsored ADR (RADX), Novan (NOVN)
TipRanks · 12/17/2025 14:10
Heart Test Laboratories Approves Indemnification Agreement
TipRanks · 12/16/2025 22:16
More
About HSCS
HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.

Webull offers HeartSciences Inc stock information, including NASDAQ: HSCS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HSCS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HSCS stock methods without spending real money on the virtual paper trading platform.